Johansson, Viktoria http://orcid.org/0000-0003-3775-7245
Erhardt, Sophie
Engberg, Göran
Kegel, Magdalena
Bhat, Maria
Schwieler, Lilly
Blennow, Kaj
Zetterberg, Henrik
Cannon, Tyrone D.
Wetterberg, Lennart
Hultman, Christina M.
Landén, Mikael
Article History
Received: 10 April 2019
Accepted: 3 July 2019
First Online: 13 July 2019
Compliance with ethical standards
:
: Dr. Tyrone D. Cannon is a consultant to Boehringer Ingelheim Pharmaceuticals, and Lundbeck A/S. Dr. Maria Bhat and Magdalena Kegel are employed by AstraZeneca AB. Dr. Kaj Blennow has served as a consultant or at advisory boards for Alector, Alzheon, CogRx, Biogen, Lilly, Novartis and Roche Diagnostics. He is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg, all unrelated to the work presented in this paper.